Estimates Revisions Intensity Therapeutics, Inc.
Stocks
INTS
US45828J2024
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 01/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.210 USD | -4.75% |
|
-17.48% | -68.70% |
| 08-11 | Intensity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Intensity Therapeutics, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- INTS Stock
- Consensus Intensity Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
